Showing results (181-190 of 354) with videos related to

Sort By:
Pageof 36
Transplantation Proceedings|December 20, 2007
Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimenW Lisik, L Schoenberg, R E Lasky, et al.
Cancer Research|November 1, 1986
Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing miceS Nomi, K Naito, B D Kahan, et al.
Anesthesiology|May 1, 1975
Humoral immunity to a metabolite of halothane, fluroxene, and enfluraneA Mathieu, D Di Padua, B D Kahan, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigenT Tanaka, H Yamagishi, N R Pellis, et al.
Therapeutic Drug Monitoring|January 1, 1990
Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrationsJ Grevel, K L Napoli, S Gibbons, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|January 1, 1984
Suppressor cells in the thoracic duct lymph of tolerant, spleen-grafted ratsS M Stepkowski, W R Duncan, J P Smith, et al.
Cancer|June 15, 1980
Specific and non-specific immunologic mechanisms of tumor growth facilitationH Yamagishi, N R Pellis, M B Mokyr, et al.
Clinical Nephrology|April 28, 2010
Addition of induction therapy offsets the hazard of marked calcineurin minimization among renal transplant recipients treated with sirolimusB D Kahan, C Benavides, L Schoenberg, et al.
Transplantation Proceedings|August 1, 1992
Prospects for synergistic immunosuppressive drug therapy in the coming decadeB D Kahan, S Gibbons-Stubber, N Tejpal, et al.
Transplantation|December 1, 1984
Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipientsA J Rogers, N Yoshimura, R H Kerman, et al.
Pageof 36